# Remotely Supervised tDCS for Slowing ALS Disease Progression

> **NCT04866771** · NA · COMPLETED · sponsor: **University of Illinois at Chicago** · enrollment: 14 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis (ALS)

## Interventions

- **OTHER:** Transcranial Direct Current Stimulation (tDCS)
- **OTHER:** Sham tDCS + anodal tDCS

## Key facts

- **NCT ID:** NCT04866771
- **Lead sponsor:** University of Illinois at Chicago
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-27
- **Primary completion:** 2024-07-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2025-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04866771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04866771, "Remotely Supervised tDCS for Slowing ALS Disease Progression". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04866771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*